Agarikonthe reference layer for psychedelic medicine
Blog Methodology Open the index
Join a trial

How to join a psilocybin clinical trial

265 studies are recruiting across 581 trial sites, 322 of them in 41 US states, and 252 of the studies publish a contact email you can write to today. Expect the process to be slower and more selective than you'd guess.

265studies recruiting
581trial sites enrolling
322US trial sites
41US states with one
“Free” has an edge to it. Studies differ on what they pay for. The consent form has a section on costs and reimbursement: read it before you commit, and ask the coordinator about anything it leaves to you, such as travel, time off work, childcare, and routine care the protocol counts as standard. Some sites reimburse travel or pay a participation stipend and some don't. We don't hold per-study cost terms in the index; the consent document is the authority.

1. Find studies, not sites

Start from the study record rather than the location. A study tells you the compound, the phase, the condition, the enrollment target and whether there's a placebo arm. Then check which of its sites you can reach. Our recruiting list is sorted by country and state, and every record links straight to its ClinicalTrials.gov registration.

2. Read the exclusions before you get attached

This is where most people fail, and usually on something they could have known in week one. The near-universal exclusions: personal or first-degree family history of psychosis or bipolar I, current lithium, uncontrolled hypertension, recent cardiac events, pregnancy. Many protocols also require you to taper off SSRIs under medical supervision, which takes six to eight weeks and has to start before screening, not after.

72countries
7.1kmapped
Nov 18build
The live index
581 recruiting sites, filterable by location Open Research & Trials, switch on Recruiting, and zoom to your area. Each record carries the NCT number and sponsor. Explore the map →

3. Email the coordinator, and say the useful things

Study coordinators are drowning in vague enquiries. A message that names the NCT number, states your age and location, lists your diagnosis and how long you've had it, names your current medications, and says you've read the exclusions will get answered ahead of one that says "I'm interested in psychedelics." Include the best time to reach you by phone; screening calls are how this moves.

4. Expect the screen to take weeks

Phone screen, then an in-person visit with psychiatric assessment, bloods and an ECG. Four to ten weeks from first email to first dose is normal. Sites drop candidates for medication conflicts, comorbid conditions and scheduling, so apply to several studies at once rather than waiting on one.

5. Understand the placebo arm before you sign

Many psilocybin trials use an active comparator, often niacin or a very low dose, specifically because a true blind is difficult when the drug is this noticeable. Ask what the comparator is and what your odds are. Ask too whether the study offers open-label crossover, meaning placebo participants get the real dose afterwards. Some do, and it changes the calculation entirely.

If trials turn out not to fit, the licensed route is Oregon or Colorado, and this walkthrough of a session covers what either would involve.